Showing results (741-750 of 1,018) with videos related to
Sort By:
Pageof 102
Anesthesia and Analgesia|January 29, 2002
Age-stratified pharmacokinetics of ketorolac tromethamine in pediatric surgical patientsRichard M Dsida, Melissa Wheeler, Patrick K Birmingham, et al.Clinics and Practice|October 28, 2025
Treating Temporomandibular Disorders Through Orthodontics: A Scoping Review of Evidence, Gaps, and Clinical GuidanceMan Hung, Jacob Daniel Gardner, Samantha Lee, et al.BMC Health Services Research|July 23, 2013
Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method studyWendy C Birmingham, Neeraj Agarwal, Wendy Kohlmann, et al.Iscience|November 26, 2020
Lymph Node Subcapsular Sinus Microenvironment-On-A-Chip Modeling Shear Flow Relevant to Lymphatic Metastasis and Immune Cell HomingKatherine G Birmingham, Meghan J O'Melia, Samantha Bordy, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 12, 2014
Posttraumatic stress disorder and responses to couple conflict: implications for cardiovascular riskCatherine M Caska, Timothy W Smith, Keith D Renshaw, et al.The Annals of Pharmacotherapy|July 1, 1994
Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoximeT F Goss, A Forrest, D E Nix, et al.Kidney International|February 1, 1994
Effect of chronically increased erythrocyte complement receptors on immune complex nephritisL A Hebert, D J Birmingham, J D Mahan, et al.Osteoarthritis and Cartilage|December 28, 2018
The star excursion balance test is a reliable and valid outcome measure for patients with knee osteoarthritisL E Kanko, T B Birmingham, D M Bryant, et al.Clinical Pharmacology and Therapeutics|October 4, 2005
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environmentEdmund Lee, Stephen Ryan, Bruce Birmingham, et al.Molecular Immunology|May 1, 2007
A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand bindingDaniel J Birmingham, Fawzi Irshaid, Katherine F Gavit, et al.Pageof 102